NCT01057628View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 13, 2010

Primary Completion Date

November 6, 2010

Study Completion Date

November 6, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

DRUG

placebo

oral

Trial Locations (5)

Unknown

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY